Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Armuzzi

Showing results (281-290 of 320) with videos related to

Pageof 32
Sort By:
United European Gastroenterology Journal|October 25, 2021
Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational studyLaurent Goessens, Jean-Frédéric Colombel, An Outtier, et al.
Gastroenterology|February 5, 2022
Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial ResultsGeert R D'Haens, William J Sandborn, Edward V Loftus, et al.
Cancers|February 15, 2022
Incident Colorectal Cancer in Inflammatory Bowel DiseaseBenedetto Neri, Maria Lia Scribano, Alessandro Armuzzi, et al.
Alimentary Pharmacology & Therapeutics|May 21, 2003
An inter- and intra-laboratory comparison of breath ¹³CO₂analysisF Perri, R M Zagari, J S Uebersax, et al.
The American Journal of Gastroenterology|October 24, 2025
The Impact of E-Cigarettes and Heat-Not-Burn Tobacco on Postoperative Recurrence of Crohn's Disease: A Multicenter International StudyTommaso Lorenzo Parigi, Olga Maria Nardone, Maria Lisa, et al.
Inflammatory Bowel Diseases|January 17, 2017
The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab BiosimilarGionata Fiorino, Natalia Manetti, Alessandro Armuzzi, et al.
The American Journal of Gastroenterology|February 2, 2024
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational StudyGabriele Dragoni, Tommaso Innocenti, Aurelién Amiot, et al.
Gut|May 2, 2020
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD studyCristina Bezzio, Simone Saibeni, Angela Variola, et al.
Inflammatory Bowel Diseases|September 10, 2019
Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD StudyLivia Biancone, Alessandro Armuzzi, Maria Lia Scribano, et al.
Gastroenterology|March 1, 2022
Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial ResultsJulián Panés, Jean-Frederic Colombel, Geert R D'Haens, et al.
Pageof 32

Showing results (281-290 of 320) with videos related to

Sort By:
Pageof 32
United European Gastroenterology Journal|October 25, 2021
Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational studyLaurent Goessens, Jean-Frédéric Colombel, An Outtier, et al.
Gastroenterology|February 5, 2022
Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial ResultsGeert R D'Haens, William J Sandborn, Edward V Loftus, et al.
Cancers|February 15, 2022
Incident Colorectal Cancer in Inflammatory Bowel DiseaseBenedetto Neri, Maria Lia Scribano, Alessandro Armuzzi, et al.
Alimentary Pharmacology & Therapeutics|May 21, 2003
An inter- and intra-laboratory comparison of breath ¹³CO₂analysisF Perri, R M Zagari, J S Uebersax, et al.
The American Journal of Gastroenterology|October 24, 2025
The Impact of E-Cigarettes and Heat-Not-Burn Tobacco on Postoperative Recurrence of Crohn's Disease: A Multicenter International StudyTommaso Lorenzo Parigi, Olga Maria Nardone, Maria Lisa, et al.
Inflammatory Bowel Diseases|January 17, 2017
The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab BiosimilarGionata Fiorino, Natalia Manetti, Alessandro Armuzzi, et al.
The American Journal of Gastroenterology|February 2, 2024
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational StudyGabriele Dragoni, Tommaso Innocenti, Aurelién Amiot, et al.
Gut|May 2, 2020
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD studyCristina Bezzio, Simone Saibeni, Angela Variola, et al.
Inflammatory Bowel Diseases|September 10, 2019
Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD StudyLivia Biancone, Alessandro Armuzzi, Maria Lia Scribano, et al.
Gastroenterology|March 1, 2022
Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial ResultsJulián Panés, Jean-Frederic Colombel, Geert R D'Haens, et al.
Pageof 32